And even if occurrence was random, there might be effects that can only be measured early on. By identifying patients before the onset of serious symptoms we can get a much more comprehensive medical history than by only looking once the symptoms are bad enough to make Alzheimer's obvious, or by monitoring large strata of the population in hopes of including enough future Alzheimer's patients in the sample